Medicaid plans

Search documents
Humana (HUM) 2025 Investor Day Transcript
2025-06-16 19:00
Humana (HUM) 2025 Investor Day June 16, 2025 02:00 PM ET Speaker0 Ladies and gentlemen, welcome to Louisville, Kentucky for Humana's twenty twenty five Investor Day. Please welcome to the stage Lisa Stoner, Vice President of Investor Relations. Speaker1 Great. Good afternoon. Welcome to Humana's twenty twenty five Investor Conference. We really appreciate you all joining today. It is great to see so many familiar faces here in the room. And thank you to everyone that's joining us virtually. Over the next th ...
Humana Gains on Strong Membership Base and Sound Cash Reserves
ZACKSยท 2025-03-31 14:15
Core Insights - Humana Inc. (HUM) is well-positioned for growth due to improved premium revenues, an aging U.S. population, acquisitions, and strong cash generation abilities [1] - The company has a strong outlook for 2025, with anticipated revenue growth and earnings per share [3][4] Revenue Growth - Humana's premium revenues increased by 10.7% year over year in 2024, driven by a solid customer base in its Medicaid and Medicare operations [5] - The company expects revenues for 2025 to be between $126 billion and $128 billion, reflecting a 7.8% improvement from 2024 [3] Earnings Performance - Humana has consistently outperformed earnings estimates, with an average surprise of 15.35% over the last four quarters [2] Strategic Acquisitions - The company has pursued strategic acquisitions to enhance its capabilities and expand its footprint, including Family Physicians Group, Curo, Enclara, iCare, and Inclusa [7] - The acquisition of Enclara improved hospice pharmacy services, while the iCare deal expanded its Medicare presence in Wisconsin [7] Financial Position - As of December 31, 2024, Humana held cash and investment securities totaling $20.4 billion, significantly exceeding its long-term debt of $11.1 billion [8] - The company anticipates GAAP cash flow from operations to be between $2.4 billion and $2.9 billion for 2025, supporting its capital deployment strategy [8] Market Demand - The growing elderly population in the U.S. is expected to sustain demand for Humana's Medicare plans, supported by its CenterWell brand introduced in 2022 [6]